Tianchen Bio-B (01779) plans to implement full circulation of H shares

Zhitongcaijing · 1d ago

According to the Zhitong Finance App, Tianchen Bio-B (01779) issued an announcement. Dr. Chen Kan (Dr. Chen) has proposed to resign as a non-executive director in order to invest more time in other business commitments, effective August 31, 2026.

The Board of Directors also announced that after considering the recommendations of the Board Nomination Committee, the Board of Directors has resolved to recommend the appointment of Mr. Xue Kailu (Mr. Xue) as a non-executive director.

The board of directors has reviewed and approved the proposal to implement the full circulation of H shares, which is to convert the Company's 1,262,882 unlisted shares (unlisted shares) into the Company's H shares (full circulation of H shares). According to the company's articles of association, the full circulation, conversion and listing of H shares is not subject to shareholders' approval at the shareholders' meeting.